Awesome A Saturday, 07/01/17 08:47:53 PM Re: None Post # of 320 The frustrating thing with this stock is whenever there is good news (as we had recently) the increase in the stock price is de minimis. However, whenever there is the hint of bad news, the stock price falls through the floor. When is the red blood cell treatment going to be ready for FDA approval? There has been far too many delays on this and right now this stock needs to show profits (forget about narrowing losses). Also, any news if this company is the target of a merger or takeover?